Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hemi (HEMI) vs Injective (INJ) Price & Performance

HemiTrade
InjectiveTrade

Price performance (Past 24H)

Key statistics

Hemi vs Injective — how do they compare? Hemi trades at Rp81.55 (market cap Rp79,52M, Rp78,55M 24h volume), while Injective trades at Rp92,050 (market cap Rp9,23T, Rp1,78T 24h volume). The key difference: Injective is far larger — about 116071.4× Hemi's market cap, and Hemi's circulating supply is 977,5M HEMI versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Hemi for 26 Days and Injective for 36 Days on average.

HEMIINJ
Market Cap
Rp79,52MRp9,23T
Volume (24h)
Rp78,55MRp1,78T
Circulating Supply
977,5M HEMI100M INJ
Typical Hold Time
26 Days36 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hemi

HEMI is currently trading at Rp81.803 with a market cap of Rp80.03 million, showing neutral technical signals across most indicators. The token trades near its pivot point of Rp82 with support at Rp76 and resistance at Rp89. With a relatively short average hold time of 26 days, the asset shows active trading but limited long-term holding. No major protocol updates or ecosystem developments were identified in recent analysis.

Overall outlook remains neutral with the token consolidating near key technical levels. Key opportunities include potential breakout above Rp89 resistance, while risks include low market cap vulnerability and limited liquidity. Investors should monitor for any significant ecosystem developments that could drive adoption beyond current trading activity.

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HEMI
58% Buy42% Sell
Avg holding period · 26 Days
INJ
29% Buy71% Sell
Avg holding period · 36 Days

Top news

Latest headlines on both assets

About Hemi

Hemi is a modular Layer-2 blockchain that bridges Bitcoin’s unmatched security with Ethereum’s programmability to create a unified ecosystem for DeFi and cross-chain interoperability. Built as a Bitcoin-Ethereum Supernetwork, Hemi integrates a Bitcoin node directly into its Ethereum-compatible hVM, allowing seamless access to Bitcoin’s state data. Through its innovative Proof-of-Proof consensus, Hemi inherits Bitcoin’s decentralized security while achieving transaction finality in about 90 minutes—bringing scalable, secure, and interoperable DeFi to both networks.

Read more on HEMI

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ